Clinical Trial Update: A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of nimotuzumab in combination with external radiotherapy for non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: YM BioSciences | Conditions: Non-small-cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED